Daidzein	daidzein	O	O
activates	activates	O	O
choline	choline	S_chemical	O
acetyltransferase	acetyltransferase	O	O
from	from	O	O
MC-IXC	mc-ixc	O	O
cells	cells	O	O
and	and	O	O
improves	improves	O	O
drug-induced	drug-induced	O	O
amnesia	amnesia	O	S_disease
.	.	O	O

The	the	O	O
choline	choline	S_chemical	O
acetyltransferase	acetyltransferase	O	O
(	(	O	O
ChAT	chat	O	O
)	)	O	O
activator	activator	O	O
,	,	O	O
which	which	O	O
enhances	enhances	O	O
cholinergic	cholinergic	O	O
transmission	transmission	O	O
via	via	O	O
an	an	O	O
augmentation	augmentation	O	O
of	of	O	O
the	the	O	O
enzymatic	enzymatic	O	O
production	production	O	O
of	of	O	O
acetylcholine	acetylcholine	S_chemical	O
(	(	O	O
ACh	ach	S_chemical	O
)	)	O	O
,	,	O	O
is	is	O	O
an	an	O	O
important	important	O	O
factor	factor	O	O
in	in	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
Alzheimer	alzheimer	O	B_disease
's	's	O	I_disease
disease	disease	O	I_disease
(	(	O	O
AD	ad	O	O
)	)	O	O
.	.	O	O

Methanolic	methanolic	O	O
extracts	extracts	O	O
from	from	O	O
Pueraria	pueraria	O	O
thunbergiana	thunbergiana	O	O
exhibited	exhibited	O	O
an	an	O	O
activation	activation	O	O
effect	effect	O	O
(	(	O	O
46	46	O	O
%	%	O	O
)	)	O	O
on	on	O	O
ChAT	chat	O	O
in	in	O	O
vitro	vitro	O	O
.	.	O	O

Via	via	O	O
the	the	O	O
sequential	sequential	O	O
isolation	isolation	O	O
of	of	O	O
Pueraria	pueraria	O	O
thunbergiana	thunbergiana	O	O
,	,	O	O
the	the	O	O
active	active	O	O
component	component	O	O
was	was	O	O
ultimately	ultimately	O	O
identified	identified	O	O
as	as	O	O
daidzein	daidzein	O	O
(	(	O	O
4',7-dihydroxy-isoflavone	4',7-dihydroxy-isoflavone	O	O
)	)	O	O
.	.	O	O

In	in	O	O
order	order	O	O
to	to	O	O
investigate	investigate	O	O
the	the	O	O
effects	effects	O	O
of	of	O	O
daidzein	daidzein	O	O
from	from	O	O
Pueraria	pueraria	O	O
thunbergiana	thunbergiana	O	O
on	on	O	O
scopolamine-induced	scopolamine-induced	O	O
impairments	impairments	O	O
of	of	O	O
learning	learning	O	O
and	and	O	O
memory	memory	O	O
,	,	O	O
we	we	O	O
conducted	conducted	O	O
a	a	O	O
series	series	O	O
of	of	O	O
in	in	O	O
vivo	vivo	O	O
tests	tests	O	O
.	.	O	O

Administration	administration	O	O
of	of	O	O
daidzein	daidzein	O	O
(	(	O	O
4.5	4.5	O	O
mg/kg	mg/kg	O	O
body	body	O	B_disease
weight	weight	O	I_disease
)	)	O	O
to	to	O	O
mice	mice	O	O
was	was	O	O
shown	shown	O	O
significantly	significantly	O	O
to	to	O	O
reverse	reverse	O	O
scopolamine-induced	scopolamine-induced	O	O
amnesia	amnesia	O	S_disease
,	,	O	O
according	according	O	O
to	to	O	O
the	the	O	O
results	results	O	O
of	of	O	O
a	a	O	O
Y-maze	y-maze	O	O
test	test	O	O
.	.	O	O

Injections	injections	O	O
of	of	O	O
scopolamine	scopolamine	S_chemical	O
into	into	O	O
mice	mice	O	O
resulted	resulted	O	O
in	in	O	O
impaired	impaired	O	O
performance	performance	O	O
on	on	O	O
Y-maze	y-maze	O	O
tests	tests	O	O
(	(	O	O
a	a	O	O
37	37	O	O
%	%	O	O
decreases	decreases	O	O
in	in	O	O
alternation	alternation	O	O
behavior	behavior	O	O
)	)	O	O
.	.	O	O

By	by	O	O
way	way	O	O
of	of	O	O
contrast	contrast	O	O
,	,	O	O
mice	mice	O	O
treated	treated	O	O
with	with	O	O
daidzein	daidzein	O	O
prior	prior	O	O
to	to	O	O
the	the	O	O
scopolamine	scopolamine	S_chemical	O
injections	injections	O	O
were	were	O	O
noticeably	noticeably	O	O
protected	protected	O	O
from	from	O	O
this	this	O	O
performance	performance	O	O
impairment	impairment	O	O
(	(	O	O
an	an	O	O
approximately	approximately	O	O
12%-21	12%-21	O	O
%	%	O	O
decrease	decrease	O	O
in	in	O	O
alternation	alternation	O	O
behavior	behavior	O	O
)	)	O	O
.	.	O	O

These	these	O	O
results	results	O	O
indicate	indicate	O	O
that	that	O	O
daidzein	daidzein	O	O
might	might	O	O
play	play	O	O
a	a	O	O
role	role	O	O
in	in	O	O
acetylcholine	acetylcholine	S_chemical	O
biosynthesis	biosynthesis	O	O
as	as	O	O
a	a	O	O
ChAT	chat	O	O
activator	activator	O	O
,	,	O	O
and	and	O	O
that	that	O	O
it	it	O	O
also	also	O	O
ameliorates	ameliorates	O	O
scopolamine-induced	scopolamine-induced	O	O
amnesia	amnesia	O	S_disease
.	.	O	O

